ArticleFrontiers in neurology2025

Limited utility of imaging-based (N) markers in predicting cerebral spinal fluid Alzheimer's disease biomarker positivity in lecanemab-eligible mild cognitive impairment.

Takeshi Kuroda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.